• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Rogers Corporation

Rogers Corporation

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Roche receives FDA clearance for next generation cobas MRSA/SA Test

    Roche receives FDA clearance for next generation cobas MRSA/SA Test

  2. Roxgold grants stock options and restricted stock units

    Roxgold grants stock options and restricted stock units

  3. Foundation Medicine Enters a Broad, Strategic Collaboration with Roche in the Field of Molecular Information in Oncology

    Foundation Medicine Enters a Broad, Strategic Collaboration with Roche in the Field of Molecular Information in Oncology

  4. Roxgold announces graduation to Tier 1 of the TSX Venture Exchange

    Roxgold announces graduation to Tier 1 of the TSX Venture Exchange

  5. Roxgold provides financing and project development update

    Roxgold provides financing and project development update

  6. Roche receives FDA Emergency Use Authorization for the LightMix® Ebola Zaire rRT-PCR Test

    Roche receives FDA Emergency Use Authorization for the LightMix® Ebola Zaire rRT-PCR Test

  7. Wide-Moat Funds That Fly Under the Radar

    These quality funds with smaller asset bases have portfolios built around solid companies.

  8. Funds Betting on Big Pharma

    Large drugmakers are out of favor, but some good funds are banking on a rebound.

  9. Dodge & Cox: Pharma Stocks Showing Value

    As incomes rise, emerging-markets consumers can afford more and better medications driving attractive growth in the pharmaceuticals sector, say the managers of Dodge & Cox International Stock.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.